Last $15.62 USD
Change Today +0.27 / 1.76%
Volume 101.5K
DVAX On Other Exchanges
Symbol
Exchange
NASDAQ CM
Frankfurt
As of 8:10 PM 12/26/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Peggy V. Phillips

Director, Chairperson of Compensation Committee and Member of Audit Committee, Dynavax Technologies Corporation
AgeTotal Calculated CompensationThis person is connected to 12 board members in 2 different organizations across 4 different industries.

See Board Relationships
60--

Background*

Ms. Peggy V. Phillips served as a Director of Treasury at CCA Global Partners, Inc. Ms. Phillips served as an Executive Vice President and Chief Operating Officer of Immunex Corporation from October 1999 to July 2002. She served as a Senior Vice President and Chief Operating Officer of Immunex Research and Development Corporation, Immunex Corp.'s former wholly owned research and development subsidiary from 1991 to January 1995. Prior to her Chief Operating Officer role, ...

Read Full Background

Corporate Headquarters*

2929 Seventh Street
Berkeley, California 94710

United States

Phone: 510-848-5100
Fax: --

Board Members Memberships*

1996-N/A
Former Chief Operating Officer, Executive Vice President and Director
2004-N/A
Former Director and Member of Audit Committee
2006-Present
Director, Chairperson of Compensation Committee and Member of Audit Committee
2006-2013
Former Independent Director and Member of Audit Committee
2014-Present
Independent Director and Chairman of Executive Compensation & Human Resources Committee

Education*

MS
University Of Idaho
BS
University Of Idaho

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
DVAX:US $15.62 USD +0.27

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ali Mortazavi Chief Executive and Director
Silence Therapeutics plc
70.0K GBP
J. Michael French Chairman, Chief Executive Officer, President and Principal Financial Officer
Marina Biotech, Inc.
$127.5K
Peter French B.Sc, M.Sc, Ph.D., MBAManaging Director, Chief Executive Officer and Director
Benitec Biopharma Limited
A$450.0K
Hans G. C. P. Schikan Chief Executive Officer and Member of Management Board
Prosensa Holding N.V.
--
Mark W. Schwartz Ph.D.Chief Executive Officer and President
Galena Biopharma, Inc.
$490.0K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact DYNAVAX TECHNOLOGIES CORP, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.